ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response

Noise-induced hearing loss (NIHL) is a major cause of hearing impairment, yet no FDA-approved drugs exist to prevent it. Targeting the mitogen activated protein kinase (MAPK) cellular pathway has emerged as a promising approach to attenuate NIHL. Tizaterkib is an orally bioavailable, highly specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutze, Richard D., Ingersoll, Matthew A., Thotam, Alena, Joseph, Anjali, Fernandes, Joshua, Teitz, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614960/
https://www.ncbi.nlm.nih.gov/pubmed/37905140
http://dx.doi.org/10.1101/2023.10.18.563007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614960/
https://www.ncbi.nlm.nih.gov/pubmed/37905140
http://dx.doi.org/10.1101/2023.10.18.563007

Ejemplares similares